Pharmacology, Toxicology and Pharmaceutical Science
Antimicrobial Resistance
100%
Staphylococcal Bacteremia
100%
Staphylococcus Aureus
100%
Meticillin
90%
Erythromycin
27%
Lactam
18%
Gentamicin
18%
Methicillin Resistant Staphylococcus Aureus Infection
18%
Sepsis
18%
Ciprofloxacin
18%
Tetracycline
18%
Antiinfective Agent
9%
Beta Lactam
9%
All Cause Mortality
9%
Molecular Epidemiology
9%
Bloodstream Infection
9%
Cotrimoxazole
9%
Linezolid
9%
Methicillin Susceptible Staphylococcus Aureus
9%
Clindamycin
9%
Vancomycin
9%
Teicoplanin
9%
Medicine and Dentistry
Staphylococcus Aureus
100%
Antibiotic Resistance
100%
Staphylococcal Bacteremia
100%
Meticillin
90%
Erythromycin
27%
Sepsis
18%
Ciprofloxacin
18%
Tetracycline
18%
Methicillin Resistant Staphylococcus Aureus Infection
18%
Gentamicin
18%
Lactam
18%
Antiinfective Agent
9%
Vancomycin
9%
Beta Lactam
9%
All Cause Mortality
9%
Clindamycin
9%
Methicillin Susceptible Staphylococcus Aureus
9%
Bloodstream Infection
9%
Trimethoprim/Sulfamethoxazole
9%
Teicoplanin
9%
Molecular Epidemiology
9%
Nursing and Health Professions
Health Care Management
100%
Antimicrobial Resistance
100%
Staphylococcal Bacteremia
100%
Meticillin
100%
Erythromycin
27%
Methicillin Resistant Staphylococcus Aureus Infection
18%
Sepsis
18%
Gentamicin
18%
Ciprofloxacin
18%
Lactam
18%
Tetracycline
18%
Cotrimoxazole
9%
Molecular Epidemiology
9%
Antiinfective Agent
9%
All Cause Mortality
9%
Bloodstream Infection
9%
Linezolid
9%
Vancomycin
9%
Teicoplanin
9%
Clindamycin
9%
Agricultural and Biological Sciences
Australians
100%
Staphylococcus Aureus
100%
Antimicrobial Resistance
100%
Meticillin
68%
Bloodstream Infection
37%
Erythromycin
18%
Tetracycline
12%
Ciprofloxacin
12%
Gentamicin
12%
Methicillin-Resistant Staphylococcus Aureus
12%
Linezolid
6%
Clindamycin
6%
Vancomycin
6%
Trimethoprim/Sulfamethoxazole
6%
Immunology and Microbiology
Staphylococcus Aureus
100%
Antimicrobial Resistance
100%
Methicillin-Resistant Staphylococcus Aureus
13%
All Cause Mortality
6%
Methicillin Susceptible Staphylococcus Aureus
6%
Molecular Epidemiology
6%